ClearPoint Neuro (CLPT) News Today $16.72 -0.73 (-4.18%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$16.73 +0.01 (+0.06%) As of 02/21/2025 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period ClearPoint Neuro (CLPT) to Release Earnings on WednesdayFebruary 21 at 2:07 AM | americanbankingnews.comClearPoint Neuro (CLPT) Projected to Post Earnings on WednesdayClearPoint Neuro (NASDAQ:CLPT) will be releasing earnings after the market closes on Wednesday, February 26, Financial Modeling Prep reports.February 21 at 2:06 AM | marketbeat.comWhile institutions own 33% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 59% ownershipFebruary 20 at 8:37 AM | finance.yahoo.comSolventum (NYSE:SOLV) vs. ClearPoint Neuro (NASDAQ:CLPT) Critical AnalysisFebruary 20 at 3:21 AM | americanbankingnews.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Sees Large Decline in Short InterestClearPoint Neuro, Inc. (NASDAQ:CLPT - Get Free Report) saw a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 653,400 shares, a decline of 22.1% from the January 15th total of 838,600 shares. Based on an average trading volume of 235,700 shares, the days-to-cover ratio is currently 2.8 days.February 16, 2025 | marketbeat.comClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for the SmartFlow CannulaFebruary 13, 2025 | finanznachrichten.deClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Sold by Legato Capital Management LLCLegato Capital Management LLC lowered its holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 23.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 122,057 shares of the company's stock aFebruary 12, 2025 | marketbeat.comClearPoint Neuro (NASDAQ:CLPT) Sets New 12-Month High - Time to Buy?ClearPoint Neuro (NASDAQ:CLPT) Reaches New 52-Week High - Here's What HappenedFebruary 6, 2025 | marketbeat.comClearPoint Neuro (NASDAQ:CLPT) Stock Price Up 8.5% - Still a Buy?ClearPoint Neuro (NASDAQ:CLPT) Trading Up 8.5% - Should You Buy?February 4, 2025 | marketbeat.comStifel maintains Clearpoint Neuro stock Buy rating, $17 targetJanuary 29, 2025 | msn.comClearPoint Neuro price target raised to $20 from $15 at B. RileyJanuary 29, 2025 | finance.yahoo.comClearPoint Neuro (NASDAQ:CLPT) Price Target Raised to $20.00B. Riley raised their price objective on ClearPoint Neuro from $15.00 to $20.00 and gave the stock a "buy" rating in a report on Tuesday.January 28, 2025 | marketbeat.comClearPoint Neuro announces FDA clearance for ‘Navigation Software Version 3.0’January 28, 2025 | markets.businessinsider.comClearPoint Neuro, Inc. (CLPT): A Bull Case TheoryJanuary 28, 2025 | msn.comClearPoint Neuro, Inc.: ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0January 27, 2025 | finanznachrichten.deClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Acquired by Conway Capital Management Inc.Conway Capital Management Inc. raised its holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 13.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 161,225 shares of the company's stock after buying an additJanuary 24, 2025 | marketbeat.comClearPoint Neuro price target raised to $30 from $17 at Lake StreetJanuary 22, 2025 | markets.businessinsider.comCLPT Stock Touches 52-Week High at $17.49 Amidst Strong Yearly GrowthJanuary 21, 2025 | msn.comClearpoint Neuro stock target lifted, buy rating on robust performanceJanuary 21, 2025 | msn.comClearPoint Neuro (NASDAQ:CLPT) Sets New 12-Month High Following Analyst UpgradeClearPoint Neuro (NASDAQ:CLPT) Reaches New 52-Week High After Analyst UpgradeJanuary 21, 2025 | marketbeat.comClearPoint Neuro (NASDAQ:CLPT) Given New $30.00 Price Target at Lake Street CapitalLake Street Capital boosted their price objective on shares of ClearPoint Neuro from $17.00 to $30.00 and gave the company a "buy" rating in a research report on Tuesday.January 21, 2025 | marketbeat.comHere's What Could Help ClearPoint Neuro (CLPT) Maintain Its Recent Price StrengthJanuary 2, 2025 | msn.comJane Street Group LLC Has $1.14 Million Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Jane Street Group LLC cut its holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 29.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 101,224 shares of the company's stock after selling 42,851 shares dDecember 30, 2024 | marketbeat.comClearpoint NeuroDecember 26, 2024 | forbes.comClearPoint: Fundamentals Continue To ImproveDecember 10, 2024 | seekingalpha.comConway Capital Management Inc. Takes $1.59 Million Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Conway Capital Management Inc. bought a new stake in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 141,500 shares of the company's stock, valued at approximately $1,586,000. ClearPoiDecember 10, 2024 | marketbeat.com48,250 Shares in ClearPoint Neuro, Inc. (NASDAQ:CLPT) Purchased by Pekin Hardy Strauss Inc.Pekin Hardy Strauss Inc. bought a new stake in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 48,250 shares of the company's stock, valued at approNovember 25, 2024 | marketbeat.comClearPoint Neuro (CLPT) Receives a Buy from Lake StreetNovember 15, 2024 | markets.businessinsider.comClearPoint Neuro announces SmartFlow Neuro Cannula FDA authorizationNovember 14, 2024 | markets.businessinsider.comQ1 Earnings Forecast for CLPT Issued By B. RileyClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) - Investment analysts at B. Riley issued their Q1 2025 earnings per share estimates for ClearPoint Neuro in a report released on Friday, November 8th. B. Riley analyst K. Bauser anticipates that the company will earn ($0.15) per share for the quaNovember 11, 2024 | marketbeat.comThe ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New ForecastsNovember 11, 2024 | finance.yahoo.comClearPoint Neuro: Near-Term Volatility Is No ConcernNovember 10, 2024 | seekingalpha.comClearPoint Neuro Achieves Record Q3 Revenue GrowthNovember 9, 2024 | markets.businessinsider.comClearPoint Neuro trading halted, volatility trading pauseNovember 9, 2024 | markets.businessinsider.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | msn.comClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...November 8, 2024 | finance.yahoo.comClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: What To ExpectNovember 6, 2024 | finance.yahoo.comClearPoint Neuro (CLPT) Gets a Buy from Lake StreetNovember 4, 2024 | markets.businessinsider.comClearPoint MR Focus Alters Brain Cases: Vanguards of Health CareNovember 4, 2024 | bloomberg.comClearPoint Neuro, Inc.: ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024October 31, 2024 | finanznachrichten.deClearPoint Neuro (CLPT) to Release Earnings on ThursdayClearPoint Neuro (NASDAQ:CLPT) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=637029)October 31, 2024 | marketbeat.comClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Up 15.1% in OctoberClearPoint Neuro, Inc. (NASDAQ:CLPT - Get Free Report) was the recipient of a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 712,200 shares, a growth of 15.1% from the September 30th total of 618,500 shares. Based on an average daily volume of 199,200 shares, the days-to-cover ratio is currently 3.6 days.October 29, 2024 | marketbeat.comTaylor Frigon Capital Management LLC Has $4.20 Million Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Taylor Frigon Capital Management LLC reduced its position in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 11.7% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 374,797 shares of the company's stock after selling 49,738 shares during the periodOctober 24, 2024 | marketbeat.comClearPoint Neuro, Inc. (CLPT): A Bear Case TheoryOctober 18, 2024 | msn.comClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024October 17, 2024 | globenewswire.comCubist Systematic Strategies LLC Takes $419,000 Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Cubist Systematic Strategies LLC acquired a new stake in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 77,750 shares of the company's stock, valueOctober 14, 2024 | marketbeat.com101,773 Shares in ClearPoint Neuro, Inc. (NASDAQ:CLPT) Bought by Squarepoint Ops LLCSquarepoint Ops LLC bought a new position in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 101,773 shares of the company's stock, valued at approximately $549,000. SquarepOctober 9, 2024 | marketbeat.comRenaissance Technologies LLC Increases Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Renaissance Technologies LLC lifted its holdings in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 562.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 169,700 shares of the company's stock after acquiringOctober 8, 2024 | marketbeat.comCubist Systematic Strategies LLC Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT)Cubist Systematic Strategies LLC bought a new position in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 77,750 shares of the company's stock, valued at approximately $419,000. Cubist SysOctober 5, 2024 | marketbeat.com Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address CLPT Media Mentions By Week CLPT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLPT News Sentiment▼0.180.60▲Average Medical News Sentiment CLPT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLPT Articles This Week▼52▲CLPT Articles Average Week Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CONMED News Today Cadre News Today Liquidia News Today InMode News Today Pulse Biosciences News Today BioLife Solutions News Today Artivion News Today MiMedx Group News Today RxSight News Today Paragon 28 News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLPT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLPT Stock Alerts